Single cell RNA-seq uncovers the nuclear decoy lincRNA PIRAT as a regulator of systemic monocyte immunity during COVID-19
This article has been Reviewed by the following groups
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
- Evaluated articles (ScreenIT)
Abstract
The systemic immune response to viral infection is shaped by master transcription factors such as NFκB or PU.1. Although long non-coding RNAs (lncRNAs) have been suggested as important regulators of transcription factor activity, their contributions to the systemic immunopathologies observed during SARS-CoV-2 infection have remained unknown. Here, we employed a targeted single-cell RNA-seq approach to reveal lncRNAs differentially expressed in blood leukocytes during severe COVID-19. Our results uncover the lncRNA PIRAT as a major PU.1 feedback-regulator in monocytes, governing the production of the alarmins S100A8/A9 – key drivers of COVID-19 pathogenesis. Knockout and transgene expression, combined with chromatin-occupancy profiling characterized PIRAT as a nuclear decoy RNA, diverting the PU.1 transcription factor from alarmin promoters to dead-end pseudogenes in naïve monocytes. NFκB-dependent PIRAT down-regulation during COVID-19 consequently releases a transcriptional brake, fueling alarmin production. Our results suggest a major role of nuclear noncoding RNA circuits in systemic antiviral responses to SARS-CoV-2 in humans.
Article activity feed
-
SciScore for 10.1101/2021.11.05.467458: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics IRB: The BioInflame study was approved by the ethics committee of the Charité - Universitätsmedizin Berlin (EA2/030/09) and the University Medical Center Marburg (55/17).
Consent: All blood donors were at least 18 years of age and provided written informed consent for use of their blood samples for scientific purposes.Sex as a biological variable Immunosuppressed, pregnant and HIV-positive patients were excluded from the study. Randomization not detected. Blinding not detected. Power Analysis not detected. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources 1 C1 + A7 antibody or FLAG antibody (Table S8), as described by Tawk et al. (45) and added to the diluted lysate, … SciScore for 10.1101/2021.11.05.467458: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics IRB: The BioInflame study was approved by the ethics committee of the Charité - Universitätsmedizin Berlin (EA2/030/09) and the University Medical Center Marburg (55/17).
Consent: All blood donors were at least 18 years of age and provided written informed consent for use of their blood samples for scientific purposes.Sex as a biological variable Immunosuppressed, pregnant and HIV-positive patients were excluded from the study. Randomization not detected. Blinding not detected. Power Analysis not detected. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources 1 C1 + A7 antibody or FLAG antibody (Table S8), as described by Tawk et al. (45) and added to the diluted lysate, followed by rotation at 4 °C over-night. FLAGsuggested: NoneCells were washed twice with BD Pharmingen Stain Buffer (Cat. No. 554656) and labelled cell suspensions were pooled and incubated with oligo-labelled AbSeq antibodies directed against CD206 (Cat. No. 940068), CD163 (Cat. No. 940058) and HLA-DR (Cat. No. 940010) for 30 minutes on ice. CD206suggested: (BD Biosciences Cat# 940068, RRID:AB_2875959)CD163suggested: (BD Biosciences Cat# 940058, RRID:AB_2875949)HLA-DRsuggested: (BD Biosciences Cat# 940010, RRID:AB_2875901)Experimental Models: Cell Lines Sentences Resources THP1 and Hek293T cells were purchased from ATCC and cultured in RPMI 1640 (Thermo Fisher), 10 % FCS, 1% penicillin/streptomycin solution (Thermo Fisher). THP1suggested: NoneLentiviral transduction: HEK293T cells were co-transfected with lentiviral vector, pseudotyping- and helper-plasmid (pVSVG and psPAX2) using lipofectamine 2000 (Thermo Fisher). HEK293Tsuggested: NoneRecombinant DNA Sentences Resources Control cells were generated using a pX458 vector with scrambled gRNA. pX458suggested: RRID:Addgene_101731)Lentiviral transduction: HEK293T cells were co-transfected with lentiviral vector, pseudotyping- and helper-plasmid (pVSVG and psPAX2) using lipofectamine 2000 (Thermo Fisher). pVSVGsuggested: RRID:Addgene_85140)psPAX2suggested: RRID:Addgene_12260)Software and Algorithms Sentences Resources After pre-processing of BD Rhapsody scRNA-seq data, read counts were loaded into the R (v3.6.3) environment and further analyzed using the Seurat package (v3.1.4). Seuratsuggested: (SEURAT, RRID:SCR_007322)S1A) were obtained through NCBI Sequence Read Archive (datasets ERR030888-ERR030903) NCBI Sequence Read Archivesuggested: (NCBI Sequence Read Archive (SRA, RRID:SCR_004891)Reads in fastq-format were quality-trimmed and mapped to the human GRCh38 reference (GENCODE), using the CLC genomics workbench. GENCODEsuggested: (GENCODE, RRID:SCR_014966)Hierarchical clustering was done using Cluster 3.0 (Eisen lab). Clustersuggested: (Cluster, RRID:SCR_013505)For pathway enrichment analysis and induced network analysis ConsensusPathDB (48) was used. ConsensusPathDBsuggested: (ConsensusPathDB, RRID:SCR_002231)Other plots were generated using GraphPad Prism, Excel or BoxPlotR (http://shiny.chemgrid.org/boxplotr/). GraphPad Prismsuggested: (GraphPad Prism, RRID:SCR_002798)Excelsuggested: NoneBoxPlotRsuggested: (BoxPlotR, RRID:SCR_015629)Sequence conservation was determined using NCBI BLASTN and the major species reference genome, respectively. BLASTNsuggested: (BLASTN, RRID:SCR_001598)BLAST hits with ≥ 20 complementary nucleotides located within a genomic range of max. BLASTsuggested: (BLASTX, RRID:SCR_001653)Results from OddPub: Thank you for sharing your data.
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
Results from scite Reference Check: We found no unreliable references.
-
